Theme: Research Strategies, propelled advancements and developments in Parkinson’s disease

Parkinsons 2017
Past Report of Parkinsons 2016

Parkinsons 2017

Sessions/Track

It is our heartiest welcome you to the “3rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 at Chicago, USA.

Parkinson’s 2017 is the leading gathering of neurologists, psychiatry, psychology researchers, and neurosurgeons with the theme of Research Strategies, propelled advancements and developments in Parkinson’s disease. Its main aim to deliver ideas for exchange of ideas and thoughts with the leading scientists which covers entire area of neurological disorder.

The live format of the conference will be accredited with CME and CPD Credits.

The objective of this session is to comprehend the inducement, Genesis and Diagnosis and prognosis including care giving of Parkinson’s disease and further hastening the revivification of Parkinson Disease.

Track 1:  Epidemiology of Parkinsons Disease

Parkinsons disease is one of the well-known age related neurodegenerative disorder, second in recurrence just to Alzheimer's disease. Parkinsons disease also causes extensive injury of the motor or sensory pathways extending beyond the pigmental brain stem nuclei. Although the disease symptoms can be controlled by Levodopa but the etiology of the Parkinsons disease remains obscure. In the United States half a million of people are diagnosed as having PD and it is predicted to be triple over next 50 years. PD appears to be slightly more in men than in women usually ranging from 1.2:1 ratio upto 1.5:1. The Parkinsons disease market in US is expected to grow at a rate of 7.3% from sales of of $1.1 billion in 2012 to $2.3 billion in 2022. The population with Parkinsons disease incurred medical expenses of approximately $14.4 per year in United States. In U.S. 15% of people with PD were in the nursing homes as compared to 9 % are of all residents aged 75-84.

Related Conferences Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference| Neurology Conference | Neurologists Conference

6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017, at Amsterdam, Netherlands,  3rd International Conference Neurological disorders  and Brain Injury during April 18-19, 2017 at London, UK,  2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 10th Annual Canadian Neuroscience Meeting during May 29-June , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons

UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, National Parkinsons Foundation, European Parkinsons Disease Association

 

Track 2:  Neurocognitive Disorders

Neurocognitive disorder is a reduction of cognitive function in one of these areas, especially when physical changes can be seen to have occurred in the cerebrum, for example, after neurological disease, brain injury or drug use. It occurs due to PD with behaviour disturbance. According to the recent projects of the United Nations between 2000 to 2050 the people over 65 years of age will exceed 1.1 billion worldwide. For estimation by 2050 Parkinsons disease will be $285 billion in the USA.

Related Conferences Parkinsons Conference| Neurology Congress| Parkinsons Disease Conference|  Neurology Conference | Neurologists Conference

7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 3rd International Conference on  Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK , 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA.

Associations on Parkinsons 

European Parkinsons Disease Association,   National Parkinsons Foundation,   Parkinson Society CanadaEuropean Neurological SocietyMovement Disorders SocietyUK Parkinsons Action Network,   American Academy of Neurology

 

Track 3:  Neuromuscular Disorders: Neuromuscular disorder is a disease that affects the peripheral nervous system which includes muscles, nerve-muscle junction, and peripheral nerves in the limbs and motor nerve cells in the spinal cord. Approximately 5600 people in the US are diagnosed with ALS each year. In US each year 750,000 people experience stroke, 11000 people suffer spinal cord injury, 500,000 people suffering from cerebral palsy, 270,000 with multiple sclerosis and 5.3 million with the after affects of a traumatic brain injury and amyotrophic lateral sclerosis.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 2nd   3rd International Conference on  Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK,  2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA. 

Associations on Parkinsons

American Academy of NeurologyUK Parkinsons Action Network,   Movement Disorders Society, European Neurological Society,   Parkinson Society CanadaNational Parkinsons FoundationEuropean Parkinsons Disease Association

 

Track 4: Risk Factors of Parkinsons disease: Risk factor for the Parkinsons disease mainly depends on age, hereditary, sex and exposure to toxins. Men are more affected than women; 25%-45% are caused by the loss of dopamine which causes rigid movements. Advancing age is a factor that is more consistently associated with an increase in the Parkinsons disease; only 5%-10% of people get PD before age of 40. It involve some of the symptoms like anxiety, cognitive problems, tremor or shaking, depression, trouble sleeping, low voice, loss of smell etc. Now a day’s Head injury and Gene variation is also a factor for Parkinsons disease.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy,  14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  3rd International Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,  6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,  1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 7th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.

Associations on Parkinsons

UK Parkinsons Action Network, Movement Disorders Society, , European Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association, National Parkinsons Foundation, American Academy of Neurology

 

Track 5:  Diagnostic and Neuroimaging for Parkinsons Disease: There is no direct treatment for Parkinsons disease as well any blood test or brain scan that confirms the diagnosis. Most PD treatments aim to restore the proper of the neurotransmitter acetylcholine and dopamine by increasing the dopamine levels. Treatment is totally based on the medical history and a neurological examination. At present there is no cure for PD, medications can lessen its symptoms and later stages surgery can be done. Parkinsons in the body; magnetic resonance imaging (MRI) is a test that produces very clear iamge of the human body without the use of X-rays. Instead of MRI uses a large magnet, radio waves, and a computer to produce these images. Medications are in three stages- first includes the drug which is known as levodopa which increase the dopamine in the brain, the second set of drugs eases some of the Parkinsons disease symptoms and the third set of drugs helps to control the non-motor symptoms including depression.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology ConferenceNeurologists Conference

13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   3rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,    2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany,  14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons

National Parkinsons FoundationUK Parkinsons Action Network, American Academy of Neurology, Movement Disorders SocietyEuropean Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association

 

Track 6:  Pathophysiology and pharmacology: The most prominent pathological lesion observed in PD occurs in the basal ganglia of the brain’s extra-pyramidal system. Non-PD patients and without nigrostriatal degeneration develope dyskinesias in response to dopaminergic. It is caused by gradual loss of nerve cells in the brain area called nigra and also by low and falling dopamine levels. The worldwide prevalence of Parkinson disease is anticipated to grow to 2.89 million cases worldwide by 2022.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy,  14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.

Associations on Parkinsons  European Parkinsons Disease Association, National Parkinsons Foundation,   UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders SocietyEuropean Neurological SocietyParkinson Society Canada

 

Track 7:  Parkinsons disease: Complications: Parkinsons disease is not thought to be a life threatening condition, but rather it has a vast effect of your personal satisfaction. With time, the sickness can bring about issues with speech, movement disorder, and brain functioning. The major complication in Parkinsons disease are blood pressure changes, depression, emotional changes, thinking difficulties, fatigue, sexual dysfunction, smell dysfunction, pain and sleep disorders.

Related Conference Parkinsons Conference | Neurology CongressParkinsons Disease Conference | Neurology Conference | Neurologists Conference

14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,    2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons  Parkinson Society Canada, European Neurological Society, Movement Disorders Society, American Academy of Neurology,   UK Parkinsons Action Network, National Parkinsons FoundationEuropean Parkinsons Disease Association

 

Track 8:  Managing life with Parkinsons disease: It is important to develope a solid PD management plan because PD is a chronic disease. Managing with Parkinsons disease includes building a health care team with proper doctors, proper intake of medications, exercises, nutrition and sleep.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy ,8th International Conference on Alzheimer’s Disease and Dementia  during October 16- 18, 2017 at Rome, Italy,  6th International Conference on Vascular Dementia  during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.

Associations on Parkinsons European Neurological Society,   Parkinson Society Canada, European Parkinsons Disease Association, National Parkinsons Foundation, Movement Disorders SocietyAmerican Academy of Neurology, UK Parkinsons Action Network

 

Track 9:  Novel Insights and therapeutics for Parkinsons disease: Parkinsons disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinsons disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.

Related Conference Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA ,13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, European Parkinsons Disease Association, National Parkinsons Foundation,    Parkinson Society Canada

 

Track 10:  Neural Transplantation: Neural transplantation is the transplantation of nerve cells and tissues into the brain and spinal cord. The cell replacement for Parkinsons Disease is based on two hypothesis- firstly the early symptoms of PD are dependent on the loss of the dopaminergic neurons in the nigrostriatal pathways and secondly the dopaminergic neurons and gathered into dopamine deficient striatum can replace those neurons which has been lost during the disease process and can reverse some extent of the major symptoms of Parkinson disease.

Related Conference Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  8th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6th International Conference on Vascular Dementia  during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany,  14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria,  1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA.   

Associations on Parkinsons  Parkinson Society Canada, UK Parkinsons Action Network, National Parkinsons Foundation,  European Parkinsons Disease Association, European Neurological Society, American Academy of Neurology, Movement Disorders Society

 

Track 11:  Gene Therapy: It is a technique which aims at treating diseases by genetically modifying population of cells into the patient body instead of using drugs and surgery to prevent from any disorder. Various methods have been developed for the gene delivery to the target cells which includes viral and non-viral systems. It is a creation of producing new cells that will produce a specific neurotransmitter which is dopamine to protect the neural system and then these cells are transplanted to the patient having Parkinsons disease because the neurons cannot be renewed further. Some important reasons are there for focusing gene therapy which includes firstly there is no cure for PD disease; secondly some genes which are identified can modulate the neuron phenotype.

Related Conference Parkinsons Conference |Neurology Congress |Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,  8th International Conference on Alzheimer’s Disease and Dementia  during October 16- 18, 2017 at Rome, Italy, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons

Movement Disorders Society, Parkinson Society Canada, American Academy of Neurology, European Neurological Society, UK Parkinsons Action NetworkNational Parkinsons Foundation, European Parkinsons Disease Association

 

Track 12:  Paediatric Movement disorders: Paediatric movement disorder is a moderately new and developing field of child neurology. While hypokinetic scatters, for example, Parkinson disease prevails in adults. There are many genetic disease which cause secondary movement disorders in childhood. Propels in paediatric movement disorder have been made by solidifying movement disorder definitions, growing the range of clinical phenotypes, understanding genetic reasons for movement disorders, and thoroughly assessing treatment adequacy for normal movement disorders. The central nervous systems typically implicated in disorders of movement are the basal and frontal cortex. Five areas were highlighted these advances: consensus definitions, newly found PRRT2 mutation, clinical and genetic range of GLUT-1 lack and neurodegeneration with brain iron aggregation (NBIA) issue, and exhaustive behavioural interventions for tics (CBIT).

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference  |Neurology Conference  | Neurologists Conference

2nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 14th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  8th International Conference on Alzheimer’s Disease and Dementia  during October 16- 18, 2017 at Rome, Italy, 3rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 7th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 13th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA.

Associations on Parkinsons  European Parkinsons Disease Association, Movement Disorders Society, National Parkinsons Foundation, Parkinson Society Canada, American Academy of Neurology, European Neurological Society, UK Parkinsons Action Network





Participation Benefits

Parkinson’s 2017 are a specially designed cluster conference which will probably unite brilliant personalities to give talks that are thought focused, and on a broad assortment of subjects associated with Parkinson’s disease and Movement Disorders, to encourage learning, inspiration and ponder – and incite discussions that matter. 

Benefits to Speakers:

·         Claim CME Credits

·         Claim CPD Credits by CPD Standards Office, UK

·         IOCM Certificate

·         Abstracts will be published with DOI number by Cross Ref

·         Handbook & Conference kits

·         Website perceivability to more than 35K guests in less than 6 months

·         Provocative Symposia's and Workshops

·         One on One Meeting with Eminent Speakers

·         Unparalleled opportunity to give presentations and network with other key opinion leaders in the field.

·         Live Streaming of the gathering

·         Get worldwide acknowledgement to your profile and Research

·         Keynote sessions by world's most famous scientists

·         Publish your compositions in the particular supporting International Journals

·         Access to Preconference Workshops

·         Group Registration Benefits at the conference

·         Research Oriented Presentations at our Gatherings

·         Encounter world class services and friendliness at the meeting

 

Benefits to Delegates:

·         Participation Certifications

·         To sharpen their skills: Delegates can analyse new ideas and procedures to make themselves extra powerful towards their work.

·         Meet experts and influencers face-to-face

·         The opportunity in an effort to blend and mingle, shape new relationships and toughen existing ones.

·         Grow: Conference will offer a unique convergence of networking, gaining knowledge of and fun right into             a single package

·         Conference attendance inspires, rejuvenates, and energizes delegates

·         Networking and informal sharing among colleagues

·         Enjoy the alluring city environment at conference venue

·         Best Hospitality services at our conference





About Conference

Parkinson’s 2017 Organising Committee, invites all the participants from all over the world to attend the Parkinson’s 2017 conference entitled “3rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 at Chicago, USA. This gathering is predominantly will focus the most recent and energizing developments in each range of Parkinson’s research, and it will offer an exceptional opportunity for specialists from all over  the world to meet, network, and distinguish with different scientific interactions.

Parkinson’s disease is a dynamic neurological disorder that influences how the individual moves, including how they talk and compose. This disease is caused by low dopamine levels. Various useful treatments, utilizing therapies (physiotherapy), surgery and medications have recognized neurological disorders and changes in the patient group. People with Parkinson’s disease also experience stiffness and they find abnormality in carrying out the movements as rapidly as before- this is known as bradykinesia.

The Parkinson’s disease market in US is expected to grow at a rate of 7.3% from sales of of $1.1 billion in 2012 to $2.3 billion in 2022. Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 40%-60% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease. African Americans have the highest death rate of 66.4% followed by whites of 64.6%, Hispanic with 55.4% and Asians with 50.8%. Parkinson’s disease strikes 50% more men than women. The economic burden of Parkinson’s disease on patients and their families in the U.S is about $14.4 billion.

 

Why to attend:

 It is our heartiest welcome you to the “3rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 in Chicago, USA.

 Parkinson’s 2017 will provide an opportunity to world researchers working in era of neurological disorders to deliver talk on their research. It will be a great opportunity to the speakers, experts, researchers from both academics and industrialist to discuss their research and views. The conference includes demonstration, symposium, workshops, B2B meetings will be also be to discuss with different tracks in the field of neurological disorder. Parkinson’s 2017 is the leading gathering of neurologists, psychiatry, psychology researchers, and neurosurgeons with the theme of Research Strategies, propelled advancements and developments in Parkinson’s disease. Its main aim to deliver ideas for exchange of ideas and thoughts with the leading scientists which covers entire area of neurological disorder.

Target audience: Neurologists, Psychiatrists, Psychologists, Neurosurgeon, Head of the department, Director, Industries, Delegates, Clinical, Community members, Professors, Researchers, Students, Scientists, Nurses.

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Parkinson disease
  • Students from Academia in the research of Neurology and Neuroscience
  • Therapists




Market Analysis

Theme: Research Strategies, propelled advancements and developments in Parkinson’s disease.

On behalf of the Conference Organizing Committee, It is our heartiest welcome you to the “3rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 in Chicago, USA.

 

Importance and Scope:

Parkinson’s disease is a progressive disease of the nervous system set apart by tremor, muscle rigidity, and moderate, imprecise movement, chiefly affecting aged and elderly individuals. It is connected with degeneration of the basal ganglia of the brain and deficiency of the neurotransmitter dopamine.

Parkinson’s disease is a progressive neurological disorder which is caused due to neurodegeneration.About 10 million of people are suffering from Parkinson’s disease globally. The global prevalence in 2012 was approximately 2.18 million cases in worldwide where $1.15 billion in US market. The Parkinson’s disease market in US is expected to grow at a rate of 7.3% from sales of of $1.1 billion in 2012 to $2.3 billion in 2022.Treatment market value is being expected to increase from $3.6 billion in 2012 to $5.3 billion in 2022. US- has the largest Parkinson’s disease therapeutics market share of 44% by 2022 which is expanding from 32% in 2012 and this will be followed by Japan, Brazil and Germany with shares of 13%, 11% and 10%. Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. In the United Kingdom approximately 127,000 people are suffering from PD. Male got 50% higher risk than females, however 4 to 5% of the cases the sufferer is younger than 40 years and it is known as Young-onset Parkinson’s disease.  NINDS funded about $90 million out of $135 million in NIH-supported PD research in USA. 

For more details, please visit: http://parkinsons.conferenceseries.com/

Why Chicago:

 Parkinson’s 2017 are the leading meeting dedicated to Neurologists and Neurosurgeons researchers with the theme “

Goal of Parkinson’s2017 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Parkinson’s Disease and Movement Disorders and share the cross-cultural experiences of various treatment procedures.

We strive to make Parkinson’s 2017 a success, with your support and high quality talks from both Parkinson’s disease and Movement Disorders communities. During the conference, we assure you that you will experience world class facilities and hospitality at the conference.

Approximately 1 million adults in USA are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 40%-60% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease

 

Conference Highlights:

Epidemiology of Parkinson’s disease

Neurocognitive Disorders

Neuromuscular Disorders

Risk factors of Parkinson’s disease

Diagnostic and Neuroimaging for Parkinson’s disease

Pathophysiology and pharmacology

Parkinson’s disease: Complications

Managing life with Parkinson’s disease

Novel Insights and therapeutics for Parkinson’s disease

Neural Transplantation

Gene therapy

Paediatric Movement disorders

Why to attend?

 

Adjoin your Target Scientists; Professors, individuals from around the globe focused on learning about Parkinson’s Disease and Movement Disorders, this is your exclusive best opportunity to reach the largest assemblage of participants from all over the world..  World-renowned speakers, the latest discoveries and most recent updates in Parkinson Disease and Movement Disorders fields, which are hallmarks of this conference.

 

Major Associations around the globe:

  • National Parkinson Foundation
  • American Parkinson Disease Association (APDA)
  • Parkinson’s disease Foundation
  • Movement Disorder Society of Australia
  • Parkinson's Unity Walk
  • Movement Disorder Society of Japan
  • Moroccan Neurological Society Movement Disorders Group
  • Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia
  • Ecuador Movement Disorders Group
  • Austrian Parkinson's Disease Society
  • Danish Movement Disorder Society
  • International Parkinson and Movement Disorder Society
  • Parkinson’s Disease and Movement Disorders Society of India

 

Around 25 associations of Parkinson Disease are there in USA

 

  • Parkinson Association of the Rockies
  • Brian Grant Foundation
  • The Michael J. Fox Foundation
  • The Foundation for Mitochondrial Medicine
  • The International Parkinson and Movement Disorder Society
  • Parkinson Alliance
  • Parkinson's Action Network (PAN)
  • Bachmann-Strauss Dystonia & Parkinson Foundation
  • Parkinson's Resource Organization
  • International Association of Parkinsonism
  • Booth Gardner Parkinson’s Care Center
  • Canadian Movement Disorders Group
  • Dallas area Parkinsonism Society
  • Indian Parkinson Foundation- The Climb
  • New Mexico Parkinson’s Disease Coalition
  • Wisconsis Parkinsons Foundation

 

Top universities 500 globally working in the field of Parkinson Disease

  • University of Bath
  • The University of Queensland
  • University of Bristol
  • University of Cambridge
  • The Imperial College of Science and Medicine
  • Duke University
  • University of Milan
  • Karolinska Institute
  • University of Hamburg
  • The University of Edinburgh
  • University of Munich
  • University of Rochester
  • University of Zurich
  • Leiden University
  • University of Bristol
  • University of Helsinki
  • Uppsala University
  • University of Freiburg
  • University of Frankfurt
  • University of Chicago Medicine

 

Top universities in USA working in the field of Parkinson Disease

  • University of California
  • University of Kansas Medical Center
  • University of South Alabama 
  • University of Florida
  • University of Miami 
  • Georgia Health Sciences University
  • Emory University
  • Northwestern University Movement Disorders Center
  • Johns Hopkins Parkinson's Disease&Movement Disorders Center
  • New York University Langone Medical Center
  • University of Rochester Medical Center
  • Duke University Medical Center
  • University of North Carolina
  • Oregon Health & Science University Parkinson Center of Oregon
  • University of Pennsylvania
  • Vanderbilt University Medical Center
  • Baylor College of Medicine

Top Universities in Chicago

University of Chicago

University of Illionois at Chicago

Loyola University Chicago

DePaul University

Columbia College Chicago

Chicago State University

Northeastern Illinois University

Roosevelt University

Saint Xavier University

North Park University

National Louis Uniersity

Harold Washington College

Truman College

Rush University

Feinberg school of Medicine

American College of Education

Kendall College

Top Hospitals in Chicago

Northwestern Memorial Hospital

Advocate Christ Medical Center

Northshore Evanston Hospital

Central DuPage Hospital

Mercy Hospital and Medical Center

Saint Joseph Hospital, Chicago

Mount Sinai Hospital, Chicago

Weiss Memorial Hospital Chicago

Norwegian- American Hospital, Chicago

Industries Associated with Parkinson Research

  • Dainippon Sumitomo Pharma
  • BioSante Pharmaceuticals
  • GlaxoSmithKline (GSK)
  • Boehringer Ingelheim




Past Conference Report

Conferenceseries.LLC takes a great pride in announcing the commencement of 2ndInternational Conference on Parkinson’s disease and Movement Disorders-2016 during December 05-07,2016 at Phoenix, USA. Parkinsons-2016 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Parkinsons and Disorders. The extremely illustrious conference hosted by Conferenceseries.LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities.

The conference was organized around the theme “Leading Innovations and Remedial Insights into the Parkinsons Disease”. The event implanted a firm relation of upcoming strategies in the field of Parkinson’s disease with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This conference brought together Leading World Parkinsons physicians, Neurosurgeons, Neuroradiologists, Clinicians, Professors, Care Specialists, Students and other professionals in which many issues in Parkinsons field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Parkinson’s disease. The eminent personalities at the conference were Harish C Pant, NINDS – NIH, USAYoland Smith, Emory University, USARudy Capildeo, Nuffield Hospital, UKSrinivas Avathvadi Venkatesan, Hershe Medical College, USA Hong Jiang, Qingdao University, China, Bennett Weinstock, Weinstock Physical Therapy, USA.

Conferenceseries.LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Alzheimer Disease & Parkinsonism, Journal of Depression and Anxiety and Journal of Neurological Disorders who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Clinical Research. Conferenceseries.LLC therefore, is glad to announce its "3rd  International Conference on Parkinson’s Disease and Movement Disorders" which will be held during September 25-26, 2017 Chicago,USA.

Mark your calendars for the upcoming extravaganza; we are hoping to see you soon!  

 





Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 25-26, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations